Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00292435
Status:
COMPLETED
Last Update Posted:
2013-10-29
First Post:
2006-02-15
Brief Title:
Efficacy and Tolerability CVI A 12-week Double-blind Randomised Placebo-controlled Multicentre Trial CVI
Sponsor:
Organization:
Boehringer Ingelheim